Expansion plans and fundraise • Oxford BioMedica has identified premises to lease in Oxford close to its existing headquarters that are suitable for a new bioprocessing facility that will include: • Four GMP suites • Fill and finish facility • Warehouse facility • The lead facility in total is around 84,000 sqft (7,800 sqm) • Planned Phase I and phase 2 expansion will fit into around 45,000 sqft (4,200 sqm) with space available for further future expansion • Facility designs and costs have been determined through a third party design consultant • Net fundraise proceeds £19.3m for capacity expansion • Expansion creates the capacity to service this rapidly growing market that is expected to be worth $800 million annually by 2026.